Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by Oliviabudqueenon May 18, 2017 11:06am
260 Views
Post# 26259579

RE:Very very nice

RE:Very very niceThe frontline retail environment looks to be interested on the hype. Some say don't buy the hype. However with respect to this dropping from the $10 range to the $8 range this support level is reasonable. It would also be worth noting that companies like $weed and Aphria have been very conservative when reporting their revenue numbers and as their book keeping starts to reflect their market share control the revenue numbers will undoubtedly increase. You have to also note that one of the biggest complaints for Canopy is that they can't keep up with demand. However as the distribution lines improve it will be a well oiled machine; if anything a dominant player with investor interests at the forefront of its business model. Take into account market share is going to be difficult to control without some consolidation. Aphria is a worth competitor that focused on profit making knowing the revenue stream would come and Beleave Pharmaceuticals has been an incredible darkhorse with tight share structure an amazing legal team with political connections unparalleled in the industry. With more companies moving forward in this direction It will be interesting to see how aggressive Canopy gets. I think they are a strong hold at this point if you already are up from 2015 levels. However if you got in during the peaks you may do well to wait until earnings. However I don't think we will be disappointed with the results. The macro climate in the U.S will not effect this company when investors are rewarded for their patience. If you are impatient I would suggest looking at copper mines for the time being. Gold is sure to start reflecting its real value. Especially with confidence lost in the American leadership to lower corporate taxes. GLTA
starsearcher40 wrote: I'm REALLY pleased with how the stock is trading.  The early morning drop was SO weak, and on such little volume that it was all but inconsequential.  The stock is dry.  Dave, with all due respect, I see no sign whatsoever of the manipulation games from a few weeks ago.  To the contrary, I see far more of the normal trading patterns through all of the brokerages, including CIBC.

And with regard to the buying through CIBC, if we look at the timeframe from the beginning of May until now, a total of 14 trading days, CIBC is UP over 750,000 shares net at an average of $8.31 over all.  Some very nice buying going on through this brokerage. ;)


Bullboard Posts